Bismuth subcarbonate

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Bismuth subcarbonate
DrugBank Accession Number
DB11281
Background

Not Available

Type
Small Molecule
Groups
Experimental, Vet approved
Structure
Thumb
Weight
Average: 509.967
Monoisotopic: 509.93537
Chemical Formula
CBi2O5
Synonyms
  • 2,4-Dioxa-1,5-dibismapentane, 1,3,5-trioxo-
  • Bismuth carbonate
  • Bismuth oxycarbonate
  • Bismuth subcarbonate
  • Bismuthyl carbonate

Pharmacology

Indication

Not Available

Pharmacology
Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Contraindications
Avoid life-threatening adverse drug events
Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Adverseeffects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AcetophenazineAcetophenazine may increase the neurotoxic activities of Bismuth subcarbonate.
AlimemazineAlimemazine may increase the neurotoxic activities of Bismuth subcarbonate.
AmisulprideAmisulpride may increase the neurotoxic activities of Bismuth subcarbonate.
AmitriptylineAmitriptyline may increase the neurotoxic activities of Bismuth subcarbonate.
AmitriptylinoxideBismuth subcarbonate may increase the neurotoxic activities of Amitriptylinoxide.
AmoxapineAmoxapine may increase the neurotoxic activities of Bismuth subcarbonate.
AripiprazoleAripiprazole may increase the neurotoxic activities of Bismuth subcarbonate.
Aripiprazole lauroxilBismuth subcarbonate may increase the neurotoxic activities of Aripiprazole lauroxil.
AsenapineAsenapine may increase the neurotoxic activities of Bismuth subcarbonate.
BenperidolBismuth subcarbonate may increase the neurotoxic activities of Benperidol.
Interactions
Identify potential medication risks
Easily compare up to 40 drugs with our drug interaction checker.
Get severity rating, description, and management advice.
Learn more
Food Interactions
Not Available

Products

Products2
Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Active Moieties
NameKindUNIICASInChI Key
Bismuth cationionicZS9CD1I8YE23713-46-4JDIBGQFKXXXXPN-UHFFFAOYSA-N
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
EstomarolBismuth subcarbonate (0.21 g/3.5g) + Aluminum hydroxide (0.18 g/3.5g) + Calcium carbonate (0.25 g/3.5g) + Magnesium carbonate (0.59 g/3.5g) + Sodium bicarbonate (2.27 g/3.5g)PowderOralLaboratorios Imperiales, S.A. De C.V.2011-05-11Not applicableUS flag
Hemorro-dol SupBismuth subcarbonate (86.4 mg) + Balsam of Peru (22.6 mg) + Belladonna (11.25 mg) + Benzocaine (50 mg) + Bismuth subnitrate (37.8 mg) + Boric acid (226.7 mg) + Ephedrine sulfate (2.5 mg) + Zinc oxide (226.7 mg)SuppositoryRectalProduits Francais Labs Inc.1981-12-311997-05-30Canada flag
Sha-lemBismuth subcarbonate (1.89 g/30mL) + Boric acid (0.95 g/30mL) + Oleic Acid (14.5 g/30mL) + Palmitic Acid (7.25 g/30mL) + Stearic acid (7.25 g/30mL)OintmentTopicalShalem Products, Inc.1992-05-08Not applicableUS flag
ยาน้ำขาวBismuth subcarbonate (75 MG/15ML) + Calcium carbonate (750 MG/15ML) + Sodium bicarbonate (480 MG/15ML)Suspensionห้างหุ้นส่วนจำกัด ห้างขายยา กรุงเทพฯฟามาซี1983-12-23Not applicableThailand flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Sha-lemBismuth subcarbonate (1.89 g/30mL) + Boric acid (0.95 g/30mL) + Oleic Acid (14.5 g/30mL) + Palmitic Acid (7.25 g/30mL) + Stearic acid (7.25 g/30mL)OintmentTopicalShalem Products, Inc.1992-05-08Not applicableUS flag

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as organic carbonic acids. These are compounds comprising the carbonic acid functional group.
Kingdom
Organic compounds
Super Class
Organic acids and derivatives
Class
Organic carbonic acids and derivatives
Sub Class
Organic carbonic acids
Direct Parent
Organic carbonic acids
Alternative Parents
Carbonate salts / Organic salts / Organic oxides / Hydrocarbon derivatives / Carbonyl compounds / Organic cations
Substituents
Aliphatic acyclic compound / Carbonate salt / Carbonic acid / Carbonyl group / Hydrocarbon derivative / Organic cation / Organic oxide / Organic oxygen compound / Organic salt / Organooxygen compound
Molecular Framework
Aliphatic acyclic compounds
External Descriptors
Not Available
Affected organisms
Not Available

Chemical Identifiers

UNII
M41L2IN55T
CAS number
5892-10-4
InChI Key
FWIZHMQARNODNX-UHFFFAOYSA-L
InChI
InChI=1S/CH2O3.2Bi.2O/c2-1(3)4;;;;/h(H2,2,3,4);;;;/q;2*+3;2*-2/p-2
IUPAC Name
dibismuth(3+) ion carbonate dioxidandiide
SMILES
[O--].[O--].[Bi+3].[Bi+3].[O-]C([O-])=O

References

General References
Not Available
ChemSpider
8003402
RxNav
19475
Wikipedia
Bismuth_subcarbonate

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
PowderOral
SuppositoryRectal
OintmentTopical
Suspension
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility90.4 mg/mLALOGPS
logP-0.25ALOGPS
logP0.25ChemAxon
logS-0.75ALOGPS
pKa (Strongest Acidic)6.05ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count3ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area63.19 Å2ChemAxon
Rotatable Bond Count0ChemAxon
Refractivity31.17 m3·mol-1ChemAxon
Polarizability3.52 Å3ChemAxon
Number of Rings0ChemAxon
Bioavailability1ChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSNot Available
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available

Drug created on December 03, 2015 16:52 / Updated on February 21, 2021 18:53